To further explore the DNA damage response in ccRCC cells and the effects on ET-1, we evaluated the canonical ataxia telangiectasia mutated/ataxia telangiectasia and Rad3-related (ATM/ATR) DNA damage pathway. The gene discussed is ATM; the disease is nonpapillary renal cell carcinoma.